Archives
-
HyperFluor 488 Goat Anti-Rabbit IgG Guide
2026-09-13
HyperFluor™ 488 Goat Anti-Rabbit IgG (H+L) Antibody provides fluorescent detection and signal amplification for rabbit primary antibodies in immunofluorescence, immunohistochemistry, immunocytochemistry, flow cytometry, and fluorescence microscopy. It should not be used as a substitute for a species-matched secondary antibody or in workflows incompatible with its sodium azide-containing buffer.
-
Thiamet G for Reliable O-GlcNAc Assays
2026-09-12
This scenario-based guide explains how Thiamet G (SKU B2048) can support controlled O-GlcNAc manipulation in viability, proliferation, cytotoxicity, tauopathy, and leukemia workflows. It covers dose selection, solution handling, orthogonal readouts, vendor evaluation, and interpretation of model-specific results.
-
MMP7 Drives EMT and Liver Fibrosis in Biliary Atresia
2026-09-11
This 2026 study identifies matrix metalloproteinase 7 (MMP7) as a mechanistic driver of liver fibrosis in biliary atresia rather than only a disease-associated biomarker. By integrating patient samples, transcriptomic analysis, biliary epithelial cell experiments, and a chronic mouse model, the authors connect MMP7-mediated E-cadherin cleavage with β-catenin nuclear translocation, epithelial–mesenchymal transition, and fibrosis.
-
Recombinant Human FGF-19 in Renal Stress Research
2026-09-11
Recombinant Human FGF-19 offers a defined way to investigate endocrine signaling alongside renal inflammatory stress. This article develops an assay-decision framework linking FGF-19 and FGFR4 binding, metabolic regulation research, and the WIP1–p38 MAPK–pyroptosis findings reported in septic acute kidney injury.
-
Thiamet G and O-GlcNAc in Ferroptosis Research
2026-09-10
Thiamet G, a selective O-GlcNAcase inhibitor, offers a mechanistic lens for studying how O-GlcNAc signaling intersects with ferroptosis and trophoblast dysfunction. This article translates recent preeclampsia findings into assay decisions while distinguishing validated evidence from hypotheses.
-
ATRX-Deficient Glioma and RTK Inhibitor Sensitivity
2026-09-10
The reference study identifies ATRX deficiency as a potential determinant of sensitivity to multi-targeted receptor tyrosine kinase and PDGFR inhibitors in high-grade glioma cells. Its combination data further support evaluating ATRX status when designing or interpreting RTK inhibitor and temozolomide studies, while recognizing that the evidence remains preclinical.
-
SARS-CoV-2 N Protein Disrupts GADD34 Immunity
2026-09-09
The reference study identifies a previously underappreciated mechanism of SARS-CoV-2 immune evasion: nucleocapsid protein redirects GADD34 mRNA into atypical G3BP1-positive foci, weakening IRF3-dependent interferon production. Its experiments connect stress-granule remodeling with impaired innate immunity and provide a mechanistic framework for studying how viral condensates support replication.
-
Luminescent ATP Detection Assay Kit in CRC
2026-09-09
Use a firefly luciferase ATP assay to connect foretinib-induced immunogenic cell death with extracellular and intracellular energy-state measurements. This workflow combines cellular ATP quantification, conditioned-medium analysis, tissue lysates, and protein-compatible sample preparation for more interpretable colorectal cancer experiments.
-
GLP-1 (9-36) amide: Practical GLP-1R Workflows
2026-09-08
GLP-1 (9-36) amide provides a practical antagonist tool for separating GLP-1 receptor signaling from ligand-driven cAMP responses and receptor cross-talk. This guide covers assay setup, peptide handling, FRET-based workflows, metabolic applications, and troubleshooting for reproducible endocrinology and type 2 diabetes research.
-
Nitrocefin Workflow for β-Lactamase Research
2026-09-08
Nitrocefin converts β-lactamase activity into a rapid yellow-to-red signal, making it useful for resistance profiling, enzyme kinetics, and inhibitor triage. This practical workflow connects routine colorimetric testing with peptide-inhibitor discovery while emphasizing controls, matrix management, and assay optimization.
-
ATP Quantification as a Ferroptosis Readout
2026-09-07
A translational framework for using ATP measurement to connect pyruvate carboxylase activity, AMPK signaling, lipid metabolism, and ferroptosis sensitivity in non-small cell lung cancer research.
-
Vitamin C, ROS/NF-κB, and Cochlear Senescence
2026-09-07
The reference study uses a D-galactose-induced HEI-OC1 cell model to show that vitamin C reduces senescence-associated changes alongside suppression of ROS accumulation and NF-κB activation. Its use of N-acetyl-L-cysteine as a redox-oriented comparator strengthens the interpretation that oxidative stress pathway modulation contributes to the observed protection, while leaving important questions about pathway causality and in vivo relevance.
-
Indole-3-pyruvic Acid: Reliable Cell Assays
2026-09-05
A scenario-based guide to using Indole-3-pyruvic acid (SKU C8759) in viability, proliferation, cytotoxicity, immune, and auxin-related workflows. It connects assay design with IPA biology, handling requirements, interpretation limits, and practical vendor-selection criteria.
-
How Sodium Collapse Executes NECSO
2026-09-04
The 2025 Nature Communications study shows that TRPM4-driven sodium influx causes necrosis by disrupting mitochondrial ion handling, oxidative phosphorylation, and the TCA cycle rather than acting only through osmotic stress. Its proposed Na⁺–NCLX–mitochondrial energy failure pathway provides a mechanistic framework for studying how ion imbalance disables ATP-dependent homeostasis and culminates in cellular swelling and lysis.
-
Hippo Signaling in Hepatobiliary Cell Maturation
2026-09-04
This 2024 bioRxiv preprint identifies HPO1 and HPO2 as spatially and temporally distinct Hippo pathway modules that govern hepatocyte and cholangiocyte maturation in mouse liver. Its combination of spatial transcriptomics, imaging, and genetic perturbation reframes Hippo signaling as a developmental checkpoint system rather than a simple controller of organ size.